Showing results (1-10 of 298) with videos related to
Sort By:
Pageof 30
Alzheimer'S Research & Therapy|July 18, 2014
Truncated and modified amyloid-beta speciesMarkus P Kummer, Michael T HenekaNature Reviews. Immunology|June 26, 2014
Innate immune activation in neurodegenerative diseaseMichael T Heneka, Markus P Kummer, Eicke LatzBehavioural Processes|November 21, 2017
Variability and temporal dynamics of novel object recognition in aging male C57BL/6 miceAndreas Traschütz, Markus P Kummer, Stephanie Schwartz, et al.Current Neuropharmacology|June 2, 2012
Impact and Therapeutic Potential of PPARs in Alzheimer's DiseaseMichael T Heneka, Elisabet Reyes-Irisarri, Michael Hüll, et al.Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|January 10, 2012
Nitric oxide decreases the enzymatic activity of insulin degrading enzyme in APP/PS1 miceMarkus P Kummer, Claudia Hülsmann, Michael Hermes, et al.Molecular Neurobiology|March 11, 2019
Dysregulation of TLR5 and TAM Ligands in the Alzheimer's Brain as Contributors to Disease ProgressionMarisol Herrera-Rivero, Francesco Santarelli, Frederic Brosseron, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 1, 2012
PPARγ/RXRα-induced and CD36-mediated microglial amyloid-β phagocytosis results in cognitive improvement in amyloid precursor protein/presenilin 1 miceMitsugu Yamanaka, Taizo Ishikawa, Angelika Griep, et al.Journal of Neurochemistry|May 22, 2009
PPARgamma and RXRgamma ligands act synergistically as potent antineoplastic agents in vitro and in vivo glioma modelsAlessio Papi, Lars Tatenhorst, Dick Terwel, et al.Journal of Neurochemistry|November 4, 2010
Restraint stress increases neuroinflammation independently of amyloid β levels in amyloid precursor protein/PS1 transgenic miceBeatriz G Perez Nievas, Thea Hammerschmidt, Markus P Kummer, et al.Pageof 30